source
- Nine midsize biopharma firms join Trump MFN drug pricing program, covering 89% of branded marketNine midsize biopharma companies have agreed to voluntarily participate in the Trump administration's Most Favored Nation drug pricing program, adding to the 17 large pharmaceutical firms that prev…
- Opinion: Trump administration’s paperwork surge hampers science and health careThe opinion piece argues that the Trump administration has expanded paperwork requirements, making it harder for scientists and Medicaid recipients to access services. Citing a federal estimate th…